The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 45
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte MICHAEL S. KOPRESKI, BERYL ASP,
BO FREDHOLM and PER-OLV GUNNARSSON
__________
Appeal No. 2004-0670
Application No. 09/276,741
__________
ON BRIEF1
__________
Before WINTERS, ADAMS, and GREEN, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 1-8, 48, 49 and 73, which are all the claims
pending in the application.
Claims 1 and 73 are illustrative of the subject matter on appeal and are
reproduced below:
1. A method of administering estramustine phosphate as an intravenous
dose, whereby the dosage of a single infusion exceeds 1300 mg.
73. A method of administering estramustine phosphate, wherein
estramustine phosphate is first encapsulated within liposomes, and
then administered intravenously.
1 Appellants waived their request for oral hearing. Paper No. 44, received April 29, 2004.
Accordingly, we considered this appeal on Brief.
Page: 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007